Molecular screening of multifocal transitional cell carcinoma of the bladder using p53 mutations as biomarkers.

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Molecular screening of multifocal transitional cell carcinoma of the bladder using p53 mutations as biomarkers.

Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Oct 1996

Xu X, Stower M J, Reid I N, Garner R C, Burns P A

Abstract excerpt

Thirteen of 28 patients (46%) with grade 2-3 multifocal transitional cell carcinoma (TCC) of the bladder were found to have p53 mutations using DNA sequence analysis. These were subsequently utilized as tumor-specific biomarkers. Analysis of 17 episodes of recurrence from five of the patients rev...

Topics

Biomarkers
Carcinoma, Transitional Cell
DNA Mutational Analysis
DNA, Neoplasm
Genes, p53
Humans
Mutation
Neoplasm Recurrence, Local
Urinary Bladder Neoplasms

Source

Open in PubMed

Identifiers

PMID: 9816132

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-9816132-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics